A state-by-state table of delta-8 legality in 2026 — plus the November 12 federal date, and why roughly half the states on the map may not follow it.
A published Sixth Circuit opinion in Hello Farms v. GR Vending reverses a $31.8 million verdict against two Curaleaf subsidiaries. The April Schedule III order is not retroactive and, without DEA registration, does not make a cannabis contract lawful in federal court.
Tennessee draws its line at detectable THC, not at the word CBD: THC-free isolate is unregulated, while full-spectrum oil, gummies and flower are ABC-licensed, 21+ products under a THCA-counting test. The state's head start on THCA does not protect it from the federal 0.4 mg per-container cap arriving December 11.
A three-judge panel refused to pause the Attorney General's April order moving state-licensed medical marijuana to Schedule III. The merits fight now runs on a consolidated, joint-brief track the court itself set in motion — likely a year of status quo before any ruling on validity.
California's Department of Cannabis Control published three further adulteration recalls on September 14 and 15. One names a licensee that bought the cannabis from someone else — and that is the part operators need to read.
Two live obligations in one state — packaging rules already in force, and a draft that turns a missed MCA email into a lost conditional license. Comment closes September 30.
Hemp CBD is legal in Texas under chapter 443, but the answer narrows on two dates: Texas already counts THCA toward total THC, and federal law counts total THC per container from December 11. Which SKUs are exposed.
THC-P occurs naturally in trace amounts and is sold as a CBD-derived synthetic — and that combination puts it in a different federal bucket than most 'synthetics.' Here is how it compares with delta-9 THC on chemistry, law and testing.
A notary's defect does not void a petition page. With that, the last legal cloud over Nebraska's medical cannabis program lifted — and the bottleneck moved to the Commission's fee rule.
P.L. 119-103 moved most of the federal hemp redefinition to December 11 — but Missouri and Illinois still hit November 12, Virginia, Ohio and Texas already bind harder, and Square's October 15 date is the earliest of all.
Up to 24 licenses across six zones, applications open until November 23 — but the social-equity certification window closes on September 11, and the form that opens it closes September 4.
The 0.4 mg per-container cap is smaller than a single Delta-8 gummy. Seven trends operators should be tracking before the federal definition changes.
The more intoxicating cannabinoid has carried the lighter legal exposure. November 12 ends that — here is the comparison table operators actually need.
IDFPR posted the form. Any adult-use dispensary in good standing can add medical sales at the medical tax rate — if it can produce a floor plan and a zoning letter.
A third legal front opened in Travis County — this one aimed at how DSHS enforces, not just what the rules say. Plus the fee claim nobody is covering.
The agency that fought rescheduling for decades filed a brief asking its administrative law judge to recommend Schedule III. The recommendation is not the decision.
A federal judge declined to pause Virginia's 2 mg THC cap, and the strictest hemp limit in the country is now in force. The operator playbook, updated.
HHC and THC differ by one chemical step — and a widening legal gap. What the 2026 federal changes mean for each, state by state.
Signed the day it was presented, P.L. 119-103 moves the total-THC redefinition and the 0.4 mg cap to December 11 — and leaves non-naturally-producible cannabinoids on November 12.
Chemically a heat step apart, legally worlds apart — until the November 12 total-THC standard closes the gap. What operators and buyers need to know.
A new AG enforcement unit, a federal lawsuit, and a 2 mg cap all land in the same month. Virginia hemp retail is about to be the most-watched market in the country.
Texas went Schedule I on most hemp THC, Virginia stood up an enforcement unit before its 2 mg cap, and Delaware wrote the East Coast THC-drinks playbook.
The Texas Supreme Court cleared DSHS to enforce its 2021 schedule — and on July 31, most hemp THC products became Schedule I. Here are the ten facts that matter.
Three THC isomers, three legal stories. Which is strongest, which states ban which, and what November 12 changes for all of them.
Cannabis businesses pay surplus-lines prices for thin coverage because insurers fear federal exposure. A new bipartisan bill takes aim at exactly that.
Barr and Craig filed the first real vehicle to avert November 12 — with a 1% total THC standard and alcohol-style rules for THC drinks. THCA flower is left out.
CAOA was filed July 16 with a hemp-recriminalization block. Sen. Sheehy says a bipartisan fix can pass. Four months out, here are the realistic paths.
One is raw acid, one is a converted cannabinoid — and the law treats them very differently. A regulatory comparison with state-by-state links.
Massachusetts certified a ballot measure to roll back legalization — the first of its kind. A rundown of what it would change for the state's licensed market.
The evidentiary record is closed. The opposition's star witness conceded marijuana meets Schedule III criteria. Here's the timeline from ALJ recommendation to final rule.
NC lawmakers sent a compromise hemp THC, kratom, and xylazine bill to the governor. The total-THC standard redraws the state's THCA flower market.
Government witnesses defended cannabis's medical value while opponents attacked the FDA's test. Here's what happened in week one and what's left.
Though HHC and HHC-A share a chemical lineage, they are distinct compounds with different potency levels and legal statuses. Understanding the gap between "not yet illegal" and "confirmed legal" is essential for any consumer navigating today's complex cannabinoid market.
The DEA's expedited rescheduling hearing runs June 29 to July 15. Who's testifying and what a Schedule III decision would change for operators.
Texas now counts THCA toward its THC limit, restricting THCA flower and concentrates. A look at the 2026 rule, the litigation, and the November federal cutover.
A regulatory guide to HHC vs THC: what HHC is, how it compares with delta-9 THC, and where its contested legal status stands in 2026.
The U.S. Embassy in Mexico warns World Cup travelers that importing marijuana, including medical cannabis, is illegal regardless of a U.S. state card.
A drug-testing trade group and a pharmaceutical company asked a federal appeals court to freeze marijuana rescheduling, reviving uncertainty over 280E relief and DEA registration.
THCA converts to delta-9 THC when heated. Here's how the law treats each and why the 2026 total-THC standard reshapes the THCA flower market.
How the law treats HHC vs THC, where they diverge, and what the 2026 federal changes mean for compliance.
Hemp companies have petitioned the Ninth and Fourth Circuits to overturn the DEA's Schedule I listing of HHC. Here's what HHC operators should do now.
State-by-state THCA status as of August 2026 with deep dives for Alabama, Georgia, North Carolina, South Carolina, and Texas — plus what changes when federal H.R. 5371 §781 takes effect November 12, 2026.
North Carolina's crackdown slipped past the election. The federal hemp definition did not. What NC retailers can sell now and which date changes first.
Texas hemp operators face TABC rule finalization, a March 31 smokable product ban, and HB 46 medical cannabis expansion reshaping the 2026 market.
Ontario's 2025 OCS THC potency testing pilot exposes label inflation in high-THC SKUs and reshapes supplier audits across the regulated adult-use catalog.
Oregon outdoor cannabis and hemp operators face 2025 wildfire smoke taint risks; practical guide to testing, labeling, and recall triage before packaging.
Greece's 2025 push to expand medical cannabis exports hinges on EU-GMP readiness across GACP cultivation, EudraLex Volume 4 manufacturing, and release.
Colombia's Decree 1138 of October 27, 2025 recognizes dried medical cannabis flower as a finished product, opening pharmacy dispensing and exports.
Health Canada removed the 60-day Notice of New Cannabis Product for dried and fresh cannabis in 2025, speeding flower launches without easing testing.
Colombia's 2025 VUCE foreign trade updates and Decree 1138 of 2025 reshape medical cannabis exports and authorize pharmacy flower under EU-GMP prescription.
Luxembourg ended prescription access to primarily THC-rich medical flower from January 1, 2025, favoring oils and standardized preparations for dosing.
Colombia's July 2025 draft decree and October 2025 Decree 1138 outline a prescription-only adult-use model dispensed through pharmacies under medical-gate.
Colombia's 2025 draft decree would authorize pharmacy sales of medical cannabis flower with new dispensing rules and marketing limits for licensed operators.
No — THCA is illegal outside Michigan's licensed cannabis system in 2026. CRA treats it as marijuana, not hemp. Retailer & consumer rules inside.
No — THCA smokables are a Class C felony in Alabama under HB 445 (July 2025). Edibles allowed under 10mg/serving, 40mg/package. ABC Board license required.
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
